WO2012010683A2 - Bâtonnets antitranspiration contenant des sels doubles - Google Patents

Bâtonnets antitranspiration contenant des sels doubles Download PDF

Info

Publication number
WO2012010683A2
WO2012010683A2 PCT/EP2011/062609 EP2011062609W WO2012010683A2 WO 2012010683 A2 WO2012010683 A2 WO 2012010683A2 EP 2011062609 W EP2011062609 W EP 2011062609W WO 2012010683 A2 WO2012010683 A2 WO 2012010683A2
Authority
WO
WIPO (PCT)
Prior art keywords
kai
weight
aluminum
composition according
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2011/062609
Other languages
German (de)
English (en)
Other versions
WO2012010683A3 (fr
Inventor
Bernhard Banowski
Barbara Heide
Bernd Anderheggen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of WO2012010683A2 publication Critical patent/WO2012010683A2/fr
Anticipated expiration legal-status Critical
Publication of WO2012010683A3 publication Critical patent/WO2012010683A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23Sulfur; Selenium; Tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants

Definitions

  • the present invention relates to antiperspirant sticks of the type of anhydrous or low-water dispersion sticks, the antiperspirant active ingredients are dispersed in a carrier, which preferably consists of a liquid, non-polar carrier material, strengthening fat or wax components and optionally surfactants.
  • Antiperspirant or antiperspirant compositions are an important part of daily personal hygiene. They should ensure that the sweat production is reduced and formed sweat does not lead to unpleasant body odor.
  • Antiperspirant active substances in particular based on aluminum salts, are already well known in the art. The use of alum, KAI (S0 4) 2 ⁇ 12 H 2 0, as deodorant for reducing body odor is known. However, the known active ingredients are still in need of improvement in their sweat-reducing or deodorising effect.
  • anhydrous according to the invention is understood to mean that the compositions contain 0 to a maximum of 5% by weight, preferably 0 to a maximum of 3% by weight, particularly preferably 0 to a maximum of 2% by weight, of free water, based on the entire composition.
  • the content of water of crystallization, water of hydration or similar molecularly bound water, which may be contained in the constituents used, in particular in any antiperspirant Wrk ⁇ contained, does not constitute free water in the context of the present application.
  • a first subject of the present invention are anhydrous cosmetic compositions containing e. at least one antiperspirant active selected from aluminum chlorhydroxides, aluminum zirconium chlorohydrates and mixtures thereof,
  • At least one double salt of the alum type having the general formula M I M I "(S0 4) 2 ⁇ x H 2 0, where M 1 is a monovalent cation selected from potassium, sodium, rubidium, cesium and ammonium Ions, M 1 "represents a trivalent cation selected from aluminum, gallium, indium, scandium, titanium and vanadium ions, and x represents a rational number in the range of 0 to 12, inclusive of 0;
  • G 0.0005-5 wt .-%, based on their weight, of at least one silica-containing compound selected from hydrophilic silicic acids and / or hydrophobically modified silicas and / or phyllosilicates,
  • composition is formulated as at 40 ° C dimensionally stable, spreadable on the skin mass.
  • the antiperspirant active ingredient a) is selected from aluminum chlorhydroxides, aluminum zirconium chlorohydrates and mixtures thereof.
  • Preferred antiperspirant active ingredients a) are water-soluble.
  • water solubility is understood as meaning a solubility of at least 5% by weight at 20 ° C., that is to say amounts of at least 5 g of the antiperspirant active are soluble in 95 g of water at 20 ° C.
  • Particularly preferred antiperspirant Wrkstoffe are selected from aluminum chlorohydrate, aluminum chlorohydrate, in particular having the general formula [Al 2 (OH) 5 CI ⁇ 1 -6 H 2 0] n, preferably [Al 2 (OH) 5 CI 2-3 ⁇ H 2 0 ] n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al 2 (OH) 4 Cl 2 ⁇ 1 -6 H 2 O] n , preferably [Al 2 (OH) 4 CI 2 ⁇ 2-3 H 2 O] n , which may be in unactivated or in activated (depolymerized) form.
  • the preparation of preferred antiperspirant agents is disclosed, for example, in US 3887692, US 3904741, US 4359456, GB 2048229 and GB 1347950.
  • aluminum sesquichlorohydrate aluminum dichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or aluminum chlorohydrex-polyethylene glycol (PEG), aluminum or aluminum zirconium glycol complexes, e.g.
  • particularly preferred antiperspirant active ingredients are selected from so-called “activated” Aluminiumchlorhydroxiden and Aluminiumzirconiumchlorhydraten, which also According to the invention, therefore, particularly preferred compositions are characterized in that the antiperspirant active ingredient a) is activated.
  • Such Wrkstoffe are known in the art and also commercially available. Their preparation is disclosed, for example, in GB 2048229, US 4775528 and US 6010688.
  • Activated aluminum chlorhydroxides and aluminum zirconium chlorohydrates are typically produced by heat treating a relatively dilute solution of the salt (e.g., about 10% by weight salt) to increase its HPLC peak 4-to-peak 3 area ratio.
  • the activated salt can then be dried to a powder, in particular spray-dried.
  • spray drying z. B. also suitable for drum drying.
  • Activated aluminum chlorhydroxides and aluminum zirconium chlorohydrates typically have a HPLC peak 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9, with at least 70% of the aluminum attributable to these peaks.
  • Antiperspirant active ingredients which are likewise preferred according to the invention are nonaqueous solutions or solubilisates of an activated aluminum or aluminum zirconium antiperspirant salt, for example according to US 6010688, by adding an effective amount of a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups , preferably propylene glycol, sorbitol and pentaerythritol, are stabilized against the loss of activation against the rapid degradation of the HPLC peak 4: peak 3 area ratio of the salt.
  • a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups preferably propylene glycol, sorbitol and pentaerythritol
  • compositions containing by weight USP: 12-45% by weight, based on the total composition, of an activated aluminum or aluminum zirconium salt, 55-82% by weight of at least one anhydrous polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, butylene glycol, diethylene glycol, dipropylene glycol, glycerol, sorbitol and pentaerythritol, more preferably propylene glycol.
  • Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols.
  • Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for. As disclosed in US 5643558 and US 6245325.
  • antiperspirant actives are basic calcium aluminum salts, as disclosed for example in US 2571030. These salts are made by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide.
  • antiperspirant actives are aluminum-zirconium complexes, such as those disclosed in US Pat. No. 4,017,599, which are buffered with salts of amino acids, especially alkali metal and alkaline earth glycinates.
  • antiperspirant actives are activated aluminum or aluminum zirconium salts, as disclosed, for example, in US Pat. No. 6,245,325 or US Pat. No. 6042816, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10, and a water-soluble calcium salt in such an amount, to provide a Ca: (AI + Zr) weight ratio of 1: 1-1: 28 and preferably 1: 2-1: 25.
  • USP 5-78% by weight
  • an activated antiperspirant aluminum or aluminum zirconium salt an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably
  • Particularly preferred solid activated antiperspirant salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, is and so much amino acid that the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • USP 48-78% by weight
  • % preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight.
  • % preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66
  • Preferred water-soluble calcium salts for the stabilization of antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof.
  • Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, valine, cysteine, serine, tryptophan, phenylalanine, Methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts are selected from glycolic acid and lactic acid.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6902723, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10, and a water-soluble strontium salt in such an amount as to provide a Sr : (Al + Zr) - weight ratio of 1: 1 - 1:28 and preferably 1: 2 - 1: 25 provide.
  • US 6902723 containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1
  • Particularly preferred solid antiperspirant activated salt compositions contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 - 13 wt .-% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: (AI + Zr) weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1 to 1:28, preferably 1: 2 to 1:25, and as much glycine, the glycine to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, and as much hydroxyalkanoic acid, the hydroxyalkanoic acid is in the (Al + Zr) weight ratio 2: 1-1: 20, preferably 1: 1-1: 10.
  • activated aluminum salts are those of the general formula Al 2 (OH) 6 . a Xa, wherein X is Cl, Br, I or N0 3 and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2.1: 1, as disclosed, for example, in US 6074632.
  • These salts generally associate some hydration water, typically 1 to 6 moles of water per mole of salt.
  • activated aluminum-zirconium salts are those which are mixtures or complexes of the aluminum salts described above with zirconium salts of the formula ZrO (OH) 2 _ pb b represent Y, wherein Y is Cl, Br, I, N0 3 or S0 4, b is a rational number from 0.8 to 2 and p is the valence of Y, as disclosed, for example, in US 6074632.
  • the zirconium salts also typically associate some hydration water associatively, typically 1 to 7 moles of water per mole of salt.
  • the zirconium salt is zirconyl hydroxychloride having the formula ZrO (OH) 2 -b Cl b , wherein b is a rational number of from 0.8 to 2, preferably from 1.0 to 1.9.
  • Preferred aluminum-zirconium salts have an Al: Zr molar ratio of 2 to 10 and a metal: (X + Y) ratio of 0.73 to 2.1, preferably 0.9 to 1.5.
  • a particularly preferred salt is aluminum zirconium chlorohydrate (ie, X and Y are Cl) which has an Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1.
  • the term aluminum-zirconium chlorohydrate includes the tri-, tetra-, penta- and octachlorohydrate forms.
  • the antiperspirant active ingredients can be present both in solubilized and in undissolved, suspended form.
  • the antiperspirant active ingredients are suspended in a carrier which is immiscible with water, it is preferred for reasons of product stability that the active substance particles have a number-average particle size of from 0.1 to 200 ⁇ m, preferably from 1 to 100 ⁇ m, particularly preferably from 3 to 80 ⁇ m and extraordinarily preferably 5 - 60 ⁇ , have.
  • Preferred aluminum salts and aluminum zirconium salts have a molar metal-to-chloride ratio of 0.9-1.3, preferably 0.9-1.1, more preferably 0.9-1.0.
  • water of hydration is associatively bound to these salts, typically 1-6 moles of water per mole of salt, corresponding to 1-16% by weight, preferably 4-13% by weight of water of hydration.
  • the preferred aluminum zirconium chlorohydrates are associated with an amino acid to prevent polymerization of the zirconium species during manufacture.
  • Preferred stabilizing amino acids are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, cysteine, valine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • the amino acid is contained in the salt in an amount of 1 to 3 moles, preferably 1 to 3 to 1.8 moles, per mole of zirconium.
  • aluminum zirconium chlorohydrate-glycine salts which are stabilized with betaine ((CH 3 ) 3 N + -CH 2 -COCf).
  • Particularly preferred corresponding compounds have a total molar (betaine + glycine) / Zr ratio of (0.1-3.0): 1, preferably (0.7-1.5): 1, and a betaine molar ratio Glycine of at least 0.001: 1 on.
  • Corresponding compounds are disclosed, for example, in US Pat. No. 7,105,691.
  • the particularly effective antiperspirant salt comprises a so-called "activated" salt, in particular one with a high HPLC peak 5-aluminum content, in particular with a peak 5 surface of at least 33%, particularly preferred at least 45%, based on the total area under peaks 2-5, as measured by HPLC of a 10% by weight aqueous solution of the active substance under conditions in which the aluminum species are resolved into at least 4 consecutive peaks (with peaks 2 - 5).
  • Preferred aluminum zirconium salts having a high HPLC peak 5-aluminum content also referred to as "E 5 AZCH" are disclosed, for example, in US 6436381 and US 6649152.
  • antiperspirant active ingredients are those aluminum zirconium salts having a high HPLC peak 5 aluminum content, which are additionally stabilized with a water-soluble strontium salt and / or with a water-soluble calcium salt.
  • Corresponding salts are disclosed, for example, in US Pat. No. 6,923,952.
  • the antiperspirant active substances can be used as non-aqueous solutions or as glycolic solubilisates.
  • compositions according to the invention are characterized in that the at least one antiperspirant active substance is present in an amount of 5 to 40% by weight, preferably 10 to 38% by weight and more preferably 13 to 35% by weight on the total weight of the anhydrous active substance (USP) in the total composition.
  • the composition contains a adstringie- rendes aluminum salt, especially aluminum chlorohydrate, for example, in powder form as Micro Dry ® Ultrafine or Microdry from Reheis, Microdry sold 323 from Summit as Chlorhydrol ® as well as in activated form as Reach ® 501 from Reheis. Under the name Reach® 301 an aluminum sesquichlorohydrate from Reheis is offered, which is likewise particularly preferred.
  • activated aluminum chlorohydrates which are available under the names Reach® 101 and Reach® 103 from Reheis / Summit.
  • aluminum zirconium tetrachlorohydrex glycine complexes which are, for example, from Reheis under the name ® Rezal 36 GP or, in activated quality than Reach ® 908 as a powder in the trade, may be particularly preferred in the present invention.
  • At least one alum-type double salt is the general one formula M I M I "(S0 4) 2 x H 2 0 ⁇ contain, where M 1 is a monovalent cation selected from potassium, sodium, rubidium, cesium and ammonium ions, M 1" is a trivalent cation, selected from aluminum, gallium, indium, scandium, titanium and vanadium ions, and x represent a rational number in the range of 0 to 12, inclusive 0.
  • KSc (S0 4 ) 2 KSc (S0 4 ) 2 , KSc (S0 4 ) 2 ⁇ 1 H 2 0, KSc (S0 4 ) 2 ⁇ 2 H 2 0, KSc (S0 4 ) 2 ⁇ 3 H 2 0, KSc (S0 4 ) 2 ⁇ 4 H 2 0, KSc (S0 4 ) 2 ⁇ 5 H 2 0, KSc (S0 4 ) 2 ⁇ 6 H 2 0, KSc (S0 4 ) 2 ⁇ 7 H 2 0, KSc (S0 4 ) 2 ⁇ 8 H 2 0, KSc (S0 4 ) 2 ⁇ 9 H 2 0, KSc (S0 4 ) 2 ⁇ 10 H 2 0, KSc (S0 4 ) 2 ⁇ 11 H z O and KSc (S0 4 ) 2 ⁇ 12 H 2 0 , NH 4 Sc (SO 4 ) 2 ,
  • KAI (S0 4 ) 2 KAI (S0 4 ) 2 , KAI (S0 4 ) 2 ⁇ 1 H 2 0, KAI (S0 4 ) 2 ⁇ 2 H 2 0, KAI (S0 4 ) 2 ⁇ 3 H 2 0, KAI (S0 4 ) 2 ⁇ 4 H 2 0, KAI (S0 4 ) 2 ⁇ 5 H 2 0, KAI (S0 4 ) 2 ⁇ 6 H 2 0, KAI (S0 4 ) 2 ⁇ 7 H 2 0, KAI (S0 4 ) 2 ⁇ 8 H 2 0, KAI (S0 4 ) 2 ⁇ 9 H 2 0, KAI (S0 4 ) 2 ⁇ 10 H 2 0, KAI (S0 4 ) 2 ⁇ 11 H z O and KAI (S0 4 ) 2 ⁇ 12 H 2 0.
  • Salts with a water content of less than 12 molecules per molecule of alum are produced by heating alum. From a temperature of about 60 ° C up to 25% of the water of crystallization already escape, preferred temperatures for further dewatering are 500 ° C or less, preferably 300 ° C or less, more preferably 250 ° C or less, most preferably 200 ° C or less, most preferably 90-150 ° C.
  • Completely dewatered alum (also called fired alum) or partially dewatered alum can be better dispersed, at least in higher concentrations, than alums having a water of crystallinity less than 12 molecules per molecule, and thus may be preferred for the stick compositions of the present invention.
  • the alum After completion of the dewatering process to the desired level of water of crystallization, the alum is brought to the desired particle size by milling or other crushing and screening processes.
  • Alum particles which have a number-average particle size of 0.1-150 ⁇ m, preferably 1-80 ⁇ m, particularly preferably 5-60 ⁇ m and extraordinarily preferably 10-30 ⁇ m, are preferred for the stick compositions according to the invention.
  • compositions according to the invention are characterized in that the double salt is selected from alum-type b) (from KAI S0 4) 2, KAI (S0 4) 2 ⁇ 1 H 2 0, KAI (S0 4) 2 ⁇ 2 H 2 0 , KAI (S0 4 ) 2 ⁇ 3 H 2 0, KAI (S0 4 ) 2 ⁇ 4 H 2 0, KAI (S0 4 ) 2 ⁇ 5 H 2 0, KAI (S0 4 ) 2 ⁇ 6 H 2 0, KAI (S0 4 ) 2 ⁇ 7 H 2 0, KAI (S0 4 ) 2 ⁇ 8 H 2 0, KAI (S0 4 ) 2 ⁇ 9 H 2 0, KAI (S0 4 ) 2 ⁇ 10 H 2 0, KAI (S0 4 ) 2 ⁇ 11 H z O and KAI (S0 4 ) 2 ⁇ 12 H 2 0, as well as mixtures thereof.
  • compositions of the invention contain at least one double salt of the alum type having the general formula M'M '' (S0 4) 2 ⁇ x H 2 0, where M 1 is a monovalent cation selected from potassium, sodium, rubidium, Cesium and ammonium ions, M 1 "represents a trivalent cation selected from aluminum, gallium, indium, scandium, titanium and vanadium ions, and x represents a rational number in the range of 0 to 12, including 0, in a total amount of 0.01 - 10 wt .-%, preferably 0.05 - 5 wt .-%, particularly preferably 0.1
  • compositions of the invention contain at least one double salt of the alum type b), is selected (from KAI S0 4) 2, KAI (S0 4) 2 ⁇ 1 H 2 0, KAI (S0 4) 2 ⁇ 2H 2 0, KAI (S0 4 ) 2 ⁇ 3 H 2 0, KAI (S0 4 ) 2 ⁇ 4 H 2 0, KAI (S0 4 ) 2 ⁇ 5 H 2 0, KAI (S0 4 ) 2 ⁇ 6 H 2 0, KAI (S0 4 ) 2 ⁇ 7 H 2 0, KAI (S0 4 ) 2 ⁇ 8 H 2 0, KAI (S0 4 ) 2 ⁇ 9 H 2 0, KAI (S0 4 ) 2 ⁇ 10 H 2 0, KAI (S0 4 ) 2 ⁇ 11 H z O and KAI (S0 4 ) 2 ⁇ 12 H 2 O, and mixtures thereof, in a total amount of 0.01 to 10 wt .-%, preferably 0.05 to 5 wt .-%, particularly preferably
  • silica-containing compound selected from hydrophilic silicas and / or hydrophobically modified silicas and / or phyllosilicates.
  • Preferred hydrophobicized phyllosilicates are selected from hydrophobized montmorillonites, hydrophobized hectorites and hydrophobized bentonites, more preferably distearonium hectorites, stearalkonium hectorites, quaternium-18 hectorites and quaternium-18 bentonites.
  • These hydrophobicized phyllosilicates are preferred in the form of a gel in an oil component, preferably in cyclomethicones and / or a non-silicone oil component, such as. For example, propylene carbonate.
  • the gelation takes place by the addition of small amounts of activators, in particular ethanol or propylene carbonate, but also water.
  • compositions according to the invention comprise at least one activator in a total amount of 0.1-3% by weight, preferably 0.3-2.0% by weight, in each case based on the total weight of the composition according to the invention.
  • Further preferred compositions according to the invention comprise at least one activator selected from ethanol, propylene carbonate and Water and mixtures thereof, in a total amount of 0.1 to 3 wt .-%, preferably 0.3 to 2.0 wt .-%, each based on the total weight of the composition according to the invention.
  • compositions according to the invention are characterized in that they comprise at least one hydrophobicized layered silicate in a total amount of 0.5-7% by weight, preferably 1-3.5% by weight, particularly preferably 2-3% by weight, in each case on the total weight of the composition according to the invention.
  • Hydrophobically modified silicas which are preferred according to the invention are selected from hydrophobically modified pyrogenic silicic acids, eg. As the commercial products of Aerosil ® series from Evonik Degussa, particularly preferably silica silylate, and silica dimethyl silylate.
  • compositions preferred according to the invention comprise at least one hydrophobically modified silica, preferably at least one hydrophobically modified fumed silica, in a total amount of 0.5-3.5% by weight, preferably 0.8-3% by weight, particularly preferably 1-2 , 5 wt .-%, most preferably 1, 5 - 2 wt .-%, each based on the total weight of the composition according to the invention.
  • Further compositions preferred according to the invention comprise at least one hydrophobized fumed silica and at least one hydrophilic silica.
  • Hydrophilic silicas which are preferred according to the invention are selected from silicon dioxide which is not modified organically or inorganically and has no organic or inorganic coating.
  • the above-mentioned feature "no organic or inorganic coating” refers to the state of the hydrophilic silica before it is mixed with the other constituents of the compositions according to the invention After mixing it is quite possible for individual constituents of the formulation to be present on the surface of the hydrophilic silica sorbed, the feature "no organic or inorganic coating" remains unaffected. Also possibly sorbed gases do not apply according to the invention as a coating. Hydrophilic silicas which are preferred according to the invention are obtainable by precipitation.
  • hydrophilic silicas which are preferred according to the invention comprise, based on the weight of the hydrophilic silica, at least 80% by weight of spherical silica particles.
  • Further hydrophilic silicas which are preferred according to the invention comprise, based on the weight of the hydrophilic silica, at least 80% by weight of silicon dioxide particles having a number-average particle diameter in the range from 2 to 15 ⁇ m, particularly preferably in the range from 5 to 10 ⁇ m.
  • Further preferred hydrophilic silicas according to the invention comprise, based on the weight of the hydrophilic silica, at least 80% by weight of silica particles having an oil absorption capacity of 0.7-1.5 cm 3 of liquid paraffin per gram of dry silicon dioxide, measured to DIN 53601.
  • hydrophilic silicas which are preferred according to the invention are obtainable by precipitation and comprise more than 80% by weight of spherical silica particles. Further inventively preferred hydrophilic silicas are obtainable by precipitation and comprise more than 80 wt .-% silica particles having a number average particle diameter in the range of 2-15 ⁇ , more preferably in the range of 5-10 ⁇ . Further preferred hydrophilic silica according to the invention Acids are obtainable by precipitation and comprise more than 80 wt .-% spherical silica particles having a number average particle diameter in the range of 2-15 ⁇ , more preferably in the range of 5-10 ⁇ . Further inventively preferred hydrophilic silicas are pyrogenic, so not available by precipitation.
  • hydrophilic silicic acids are available as commercial product SB-705 from Miyoshi Kasei, a spherical silica gel or spherical silica particles with the INCI name Silica having a number-average particle diameter of 5 to 6 ⁇ m and a specific surface area of about 600 m 2 / g.
  • Further preferred hydrophilic silicic acids are available as a commercial product Aerosil from Evonik Degussa, for example Aerosil 130, Aerosil 200, Aerosil 255, Aerosil 300 or Aerosil 380.
  • hydrophilic silicas are also available as commercial products: CAB-O-SIL Fumed Silica (Cabot), CAB-O-SIL EH-5 (Cabot), CAB-O-SIL HS-5 (Cabot), CAB-O-SIL LM-130 (Cabot), CAB-O-SIL MS-55 (Cabot), CAB- O-SIL M-5 (Cabot), Cosmedia Silc (Cognis), Neosil PC 50S (Ineos Silica), Sorbosil BFG 54 (Ineos Silica), Sorbosil AC33 (Ineos Silica), Sorbosil AC 35 (Ineos Silica), Sorbosil AC 37 (Ineos Silicas), Sorbosil AC 39 (Ineos Silica), Wacker HDK N 20 (Wacker chemistry), Wacker HDK S 13 (Wacker chemistry), Wacker HDK T 30 (Wacker chemistry), Wacker HDK V 15 (Wacker
  • compositions according to the invention comprise at least one hydrophilic silica in a total amount of 0.0005-5 wt.%, Preferably 0.001-2 wt.%, Particularly preferably 0.01-1 wt.%, Most preferably 0.05. 0.7 wt .-% and more preferably 0.1 to 0.4 wt .-%, each based on the total composition.
  • compositions according to the invention are formulated as a stick and in addition to the sweat-reducing active ingredients usually contain at least one cosmetic oil as a carrier for the particulate sweat-reducing active ingredient.
  • Preferred compositions according to the invention are characterized in that the anhydrous carrier d) comprises at least one cosmetic oil.
  • non-volatile oils are understood as meaning oils which have a vapor pressure of less than 2.66 Pa (0.02 mm Hg) at 20 ° C. and an ambient pressure of 1013 hPa.
  • volatile oils are understood as meaning oils which at 20 ° C. and an ambient pressure of 1013 hPa have a vapor pressure of 2.66 Pa-40,000 Pa (0.02 mm-300 mm Hg), preferably 13-12,000 Pa (0.1-90 mm Hg), more preferably 15-8000 Pa, most preferably 300-3000 Pa.
  • Cosmetic oils preferred according to the invention are selected from silicone oils, to which z.
  • dialkyl and alkylaryl such as cyclopentasiloxane, cyclohexasiloxane, dimethyl polysiloxane, low molecular weight phenyl trimethicone and Methylphenylpolysiloxan, but also include hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane.
  • Particularly preferred are volatile silicone oils, which may be cyclic, such as.
  • octamethylcyclotetrasiloxane decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane and mixtures thereof, as described for.
  • DC 244, 245, 344 and 345 from Dow Corning vapor pressure at 20 ° C about 13 - 15 Pa
  • volatile linear silicone oils having 2 to 10 siloxane units, in particular hexamethyldisiloxane (L 2 ), octamethyltrisiloxane (L 3 ), decamethyltetrasiloxane (L 4 ) and any mixtures of two and three of L 2 , L 3 and / or L 4 such mixtures, as they are for.
  • Dow Corning® 2-1 184 Dow Corning® 200 (0.65 cSt) and Dow Corning® 200 (1.5 cSt) from Dow Corning.
  • Another preferred volatile silicone oil is a low molecular weight phenyl trimethicone having a vapor pressure at 20 ° C of about 2000 Pa as available, for example, from GE Bayer Silicones / Momentive under the name Baysilone Fluid PD 5.
  • Volatile silicone oils are excellently suitable carrier oils for antiperspirant compositions which are preferred according to the invention, since they give them a pleasant feeling on the skin and a low degree of tackiness.
  • Antiperspirant compositions which are particularly preferred according to the invention are therefore, by virtue of a content of at least one volatile silicone oil, of 30-95% by weight, preferably 40-93% by weight, particularly preferably 50-90% by weight, very preferably 55% 85 wt .-%, each based on the total composition characterized.
  • At least one volatile non-silicone oil may also be present.
  • Preferred volatile non-silicone oils are selected from C 8 -C 6 isoparaffins, especially isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, and isohexadecane, and mixtures thereof.
  • This at least one volatile non-silicone oil is also preferably in a total amount of 30-95% by weight, preferably 40-93% by weight, more preferably 50-90% by weight, most preferably 55-85% by weight, in each case based on the total composition.
  • volatile silicone oils, isoparaffins in particular isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane, and mixtures of volatile silicone oils and isoparaffins, in particular isododecane, isohexadecane or isoeicosane, are particularly preferred .
  • Particularly preferred isoparaffins are selected from isodecane, isoundecane, isododecane, isotridecane, and mixtures of isodecane, isoundecane, isododecane and / or isotridecane.
  • compositions according to the invention are characterized in that the at least one carrier oil under normal conditions d) at least one isoparaffin oil, in particular isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane, particularly preferably isodecane, isoundecane, isododecane, isotridecane, Isotetradecane, isopentadecane, isohexadecane and mixtures of isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane and / or isohexadecane.
  • isoparaffin oil in particular isodecane, isoundecane, isododecane, isotridecane, isotetradecan
  • compositions preferred according to the invention contain as carrier liquid d) under normal conditions a mixture of d) i) a volatile silicone oil selected from And d) ii) at least one isoparaffin oil, in particular isodecane, isoundecane, isododecane, isotridecane, isotetradecan, isopentadecane, isohexadecane and isoeicosane, particularly preferably isodecane, isoundecane, isododecane, isotridecane, isotetradecane, cyclic thiols and linear polydimethylsiloxanes having 2-10 siloxane units; Isopentadecane, isohexadecane and mixtures of isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane and / or isohexade
  • compositions according to the invention contain as carrier liquid under normal conditions d) at least one n-alkane having nine to 15 carbon atoms, so n-nonane, n-decane, n-undecane, n-dodecane, n-tridecane, n-tetradecane and n-pentadecane and mixtures thereof. Particularly preferred are n-tridecane, n-tetradecane and n-pentadecane and mixtures thereof.
  • mixtures of isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane, n-tridecane, n-tetradecane and n-pentadecane are particularly preferred.
  • mixtures of isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane, n-tridecane, n-tetradecane and n-pentadecane in which the proportion of n-alkanes is 5-45% by weight, based on the weight of the total Mix, matter.
  • particularly preferred antiperspirant compositions according to the invention may further contain at least one nonvolatile cosmetic oil selected from nonvolatile silicone oils and non-volatile non-silicone oils Due to the relatively rapid evaporation of the volatile oils, solid, insoluble constituents, in particular the antiperspirant active ingredients, can be visualized on the skin as an unsightly residue These residues can be successfully masked with a nonvolatile oil In addition, with a mixture of non-volatile and volatile oil parameters such as skin feel, visibility of the residue s and stability of the suspension are fine-tuned and better adapted to the needs of consumers. Of course, it is also possible to formulate anhydrous antiperspirant compositions with a low level of volatile oils or even without volatile oils.
  • Preferred nonvolatile silicone oils are selected from higher molecular weight linear dimethyl polysiloxanes, commercially available for. B. under the name Dow Corning ® 200 fluid with kinematic viscosities (25 ° C) in the range of 5 - 100 cSt, preferably 6 - 50 cSt or even 5 - 10 cSt, and Baysilon ® 350 M (with a kinematic viscosity (25 350 ° C.
  • preferred silicone oils according to the invention are selected from silicones of the formula (Sil-1), where x is selected from integers of 1-20.
  • a preferred silicone oil of formula (Sil-1) is available under the INCI name Phenyl Trimethicone in various grades, viscosities and volatilities.
  • a non-volatile phenyl trimethicone is available, for example, from Dow Corning under the name Dow Corning 556.
  • Natural and synthetic hydrocarbons such as paraffin oils, C 8 -C 30 - isoparaffins, especially isoeicosane, polyisobutenes or polydecenes, the ®, for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004G from Nestle are available, as well as 1, 3-di- (2-ethylhexyl) -cyclohexane (obtainable, for. example, under the trade name Cetiol ® S from Cognis) also belong to the present invention the preferred non-volatile non-silicone oils.
  • paraffin oils C 8 -C 30 - isoparaffins, especially isoeicosane, polyisobutenes or polydecenes, the ®, for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004G from Nestle
  • non-volatile non-silicone oils which are preferred according to the invention are selected from the benzoic acid esters of linear or branched C 8 . 22 - alkanols. Particularly preferred are benzoic C12-C15 alkyl esters, z. B. available as a commercial product Finsolv ® TN, benzoic acid isostearyl, z. B. available as a commercial product Finsolv ® SB, ethylhexyl benzoate, z. B. available as a commercial product Finsolv ® EB, and benzoic acid octyl dodecylester, z. B. available as a commercial product Finsolv ® BOD.
  • Benzoic acid ester oils of this type are particularly suitable for masking antiperspirant active substance residues, since their refractive index comes very close to the particularly effective aluminum-zirconium mixed salts.
  • Further non-volatile non-silicone oils which are preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction.
  • Preferred oils are alcohol 2-hexyldecanol (Eutanol ® G 16) Octyldodecanol (Eutanol ® G) and 2-ethylhexyl alcohol.
  • More preferred non-volatile non-silicone oils are chosen from mixtures of Guerbet alcohols and Guerbet alcohol esters, for example the commercial product Cetiol ® PGL (hexyldecanol and hexyldecyl laurate).
  • non-volatile non-silicone oils are chosen from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 _ th 30 fatty acids, provided that they are liquid under normal conditions.
  • natural oils eg soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, rapeseed oil, olive oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of the coconut oil is preferably in a total amount of 0, 1-5 wt .-%, preferably 0.2 to 3 wt .-%, particularly preferably 0.5 to 1, 5 wt .-%, each based on the total weight of composition according to the invention.
  • synthetic triglyceride oils in particular Capric / Caprylic triglycerides, z.
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the dicarboxylic acid esters of linear or branched C 6 -C 0 -alkanols, in particular di (2-ethylhexyl) adipate, dioctyl adipate, dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2 ethylhexylsuccinate and di (2-hexyldecyl) succinate.
  • dicarboxylic acid esters of linear or branched C 6 -C 0 -alkanols in particular di (2-ethylhexyl) adipate, dioctyl adipate, dioctyl sebacate, diisopropyl sebacate, diocty
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the esters of linear or branched saturated or non-volatile non-silicone oils unsaturated fatty alcohols having 6 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated.
  • These include hexyldecyl (eutanol ® G 16 S), hexyldecyl, isononyl isononanoate, 2-ethylhexyl and 2-ethylhexyl.
  • non-volatile non-silicone oils are selected from the addition products of 1 to 5 propylene oxide units of mono- or polyhydric C 8 _ 22 - alkanols such as octanol, decanol, decane diol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Wtconol ® APM).
  • non-volatile non-silicone oils are selected from the addition products of at least 6 ethylene oxide and / or propylene oxide units onto mono- or polyhydric C 3 _ 22 -Alka- nole such as glycerol, butanol, butanediol, myristyl alcohol and stearyl alcohol, which if desired, be esterified can, for.
  • PPG-14 butyl ether Ucon Fluid ® AP
  • PPG-9-butyl ether Breox B25 ®
  • PPG-10 butanediol Macol ® 57
  • PPG-15 stearyl ether Arlamol ® E
  • Glycereth-7 Glycereth-7 -diisononanoat.
  • Particularly preferred compositions according to the invention contain, by weight in each case, from 3 to 20% by weight, preferably from 4 to 18% by weight and in particular from 5 to 17% by weight of PPG-14-butyl ether.
  • non-volatile non-silicone oils are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, eg. As glycerol carbonate, dicaprylyl (Cetiol ® CC) or the esters according to the teaching of DE 19756454 A1.
  • Further oils which may be preferred according to the invention are selected from the esters of dimers of unsaturated C 2 -C 22 -fatty acids (dimer fatty acids) with monovalent linear, branched or cyclic C 2 -C 8 -alkanols or with polyvalent linear or branched C 2 - C 6 alkanols.
  • compositions according to the invention are characterized in that the carrier oil which is liquid under normal conditions is selected from volatile silicone oils, nonvolatile silicone oils, volatile hydrocarbon oils, branched saturated or unsaturated fatty alcohols containing 6 to 30 carbon atoms, triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 .
  • oil component types which are particularly preferred according to the invention are isoparaffin oils, in particular isododecane, isohexadecane and isoeicosane.
  • isododecane, isohexadecane and isoeicosane are among the volatile oil components. Since they evaporate relatively quickly after application to the skin, the hydrophobic loading of the antiperspirant active ingredient particles is reduced. Such volatile oil components thus support the release of the antiperspirant.
  • a proportion of the oil components of at least 80% by weight has a refractive index n D of 1.39-1.51.
  • n D refractive index
  • compositions according to the invention comprise at least one oil in a total amount of 30-75% by weight, preferably 40-60% by weight, particularly preferably 42-50% by weight, in each case based on the total weight of the composition.
  • Further preferred compositions according to the invention contain a total of 30-70% by weight of at least one liquid cosmetic oil which contains 10 to 50% by weight of at least one volatile oil selected from volatile cyclic silicones, volatile linear silicones and n Alkanes having from nine to 15 carbon atoms, and mixtures thereof, and in addition to the at least one volatile oil, a total of 1-30% by weight of at least one nonvolatile oil, all of the weight percentages being based on the total weight of the composition ,
  • Particularly preferred compositions according to the invention are characterized in that the liquid carrier component d) i)
  • a non-polar oil preferably a volatile silicone oil
  • compositions which are particularly preferred according to the invention, in each case based on their weight,
  • antiperspirant active substances selected from aluminum chlorhydroxides, aluminum zirconium chlorohydrates and mixtures thereof,
  • Suitable solidifying fat or wax components are all saturated, linear fatty acids and fatty alcohols having 14-22 carbon atoms, triglycerides of saturated fatty acids having 14-22 carbon atoms, saturated linear wax esters (fatty acid fatty alcohol esters) having 28-44 carbon atoms. Atoms or mixtures thereof.
  • Further preferred antiperspirant sticks according to the invention contain a total of 15-25% by weight of at least one wax component which is solid under normal conditions, with a total of 12-22% by weight of at least one linear and saturated C 4 -C 22 -alkanol, 0.5-5% by weight .-% of at least one wax having a melting point of 65 to 150 ° C and 0.5 to 8 wt .-% of at least one wax having a melting point of 25 to ⁇ 50 ° C are included.
  • wax components that are solid under normal conditions, linear and saturated C 4 -C 22 alkanols, natural vegetable and animal waxes and their synthetic replicas such.
  • Synthetic beeswax furthermore the waxes, which are explicitly mentioned below as suitable wax components.
  • Other components that are solid under normal conditions include, for example, ethoxylated alkanols, such as ceteareth-12 not to the wax components. Even under normal conditions solid alkanoic acids are not among the wax components.
  • the sticks according to the invention based in each case on their total weight, a total of 12-22 wt .-%, preferably 13-20 wt .-%, particularly preferably 14-19 wt .-%, most preferably 15-18 wt .-%, at least one linear and saturated C 4 -C 22 alkanol.
  • Preferred C 4 -C 22 alkanols are selected from myristyl alcohol, cetyl alcohol, stearyl alcohol, arachidyl alcohol and behenyl alcohol and mixtures thereof. Particularly preferred are cetyl alcohol, stearyl alcohol and mixtures thereof. Stearyl alcohol is extremely preferred. Further preferred is the sole use of stearyl alcohol.
  • Further inventively preferred pens contain, based on their total weight, a total of 12 to 22 wt .-%, a mixture of two or three linear and saturated C 4 -C 22 -alkanols, wherein 0.1 to 3 wt .-%, based are contained on the entire stick, arachidyl alcohol and / or behenyl alcohol and the remaining C 4 -C 22 alkanol consists of stearyl alcohol.
  • the preferred sticks according to the invention based in each case on their total weight, contain a total of from 0.5 to 5% by weight, preferably from 1 to 4% by weight, more preferably from 1 to 5% by weight.
  • waxes according to the invention having a melting point of 65-150 ° C. are natural vegetable waxes, in particular candelilla wax, carnauba wax, Japan wax, sugarcane wax, ouricoury wax, cork wax, sunflower wax, fruit waxes such as orange waxes, lemon waxes and grapefruit wax, and animal waxes, in particular beeswax, shellac wax and spermaceti, as well as synthetic replicas of natural waxes such.
  • B. synthetic beeswax For the purposes of the invention, it may be particularly preferred to use hydrogenated or hardened waxes.
  • the waxes which are likewise preferred according to the invention include polyalkylene waxes, in particular polyethylene waxes, paraffin waxes and polyethylene glycols which have only polyethylene glycol units in the molecule and have a molecular weight of at least 3 million daltons, in particular compounds with the INCI name PEG- 90M, C 2 oC 4 o-dialkyl esters of dimer acids, C30-50 alkyl beeswax and alkyl and alkylaryl esters of dimer fatty acids.
  • polyalkylene waxes in particular polyethylene waxes, paraffin waxes and polyethylene glycols which have only polyethylene glycol units in the molecule and have a molecular weight of at least 3 million daltons, in particular compounds with the INCI name PEG- 90M, C 2 oC 4 o-dialkyl esters of dimer acids, C30-50 alkyl beeswax and alkyl and alkylaryl esters of dimer fatty acids.
  • a particularly preferred wax component is selected from at least one ester of a saturated, monohydric C 6 -C 60 -alcohol and a saturated C 8 -C 36 -monocarboxylic acid.
  • lactides the cyclic double esters of ⁇ -hydroxycarboxylic acids of the corresponding chain length, also belong thereto.
  • Esters of fatty acids and long-chain alcohols have been found to be particularly advantageous for the composition of the present invention because they give the antiperspirant preparation excellent sensory properties and overall high stability to the pin.
  • the esters are composed of saturated, branched or unbranched monocarboxylic acids and saturated, branched or unbranched monohydric alcohols.
  • esters of aromatic carboxylic acids or hydroxycarboxylic acids eg 12-hydroxystearic acid
  • saturated, branched or unbranched alcohols are used according to the invention, provided that the wax component has a melting point of 65-150 ° C. It is particularly preferred to choose the wax components from the group of esters of saturated, branched or unbranched alkanecarboxylic acids having a chain length of 12 to 24 carbon atoms and the saturated, branched or unbranched alcohols having a chain length of 16 to 50 carbon atoms, which has a melting point from 65 - 150 ° C. In particular, as a wax component C 6 . 36 alkyl stearates and C 8 .
  • a particularly preferred embodiment of the invention contains as wax component a C 2 oC 40 alkyl stearate. This ester is known under the name Kester ® K82H or Kesterwachs ® K80H and is sold by Koster Keunen Inc.. Further particularly preferred wax components with a melting point of 65-150 ° C.
  • triglycerides of saturated and optionally hydroxylated C 2 -3o fatty acids such as hardened triglyceride fats (hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil), glyceryl tribehenate (tribehenin) or glyceryl tri-12- hydroxystearate, furthermore synthetic full esters of fatty acids and glycols or polyols having 2 to 6 carbon atoms, as long as they have a melting point above 65 to 150 ° C, for example preferably C 18 to C 36 acid triglycerides.
  • hydrogenated castor oil is particularly preferred as the wax component.
  • each based on their total weight a total of 15 to 25 wt .-% of at least one solid under normal conditions wax component, wherein a total of 12 to 22 wt .-% of at least one linear and saturated C 4 -C 22 alkanol, selected from Cetyl alcohol, stearyl alcohol, arachidyl alcohol and behenyl alcohol and mixtures thereof, a total of 0.5 to 5 wt .-% of at least one wax having a melting point of 65 to 150 ° C and 0.5 to 8 wt .-% of at least one wax having a melting point of 25 to ⁇ 50 ° C are included.
  • Further inventively preferred pens contain, based on their total weight, a total of 15 to 25 wt .-% of at least one solid under normal conditions wax component, wherein a total of 12 to 22 wt .-% of a linear and saturated C 4 -C 22 alkanol, the only is selected from stearyl alcohol, further comprising a total of 0.5 to 5 wt .-% of at least one wax having a melting point of 65 to 150 ° C and 0.5 to 8 wt .-% of at least one wax having a melting point of 25 to ⁇ 50 ° C are included.
  • Further inventively preferred pens contain, based on their total weight, a total of 15 to 25 wt .-% of at least one solid under normal conditions wax component, wherein a total of 12 to 22 wt .-% of a mixture of two or three linear and saturated C 4 -C 22 Alkanols, wherein 0.1 to 3 wt .-%, based on the total stick, arachidyl alcohol and / or behenyl alcohol and the remaining C 4 -C 22 alkanol consists of stearyl alcohol, further a total of 0.5 to 5 wt.
  • a total of 15 to 25 wt .-% of at least one solid under normal conditions wax component wherein a total of 12 to 22 wt .-% of at least one linear and saturated C 4 -C 22 alkanol, selected from cetyl alcohol, Stearyl alcohol, arachidyl alcohol and behenyl alcohol and mixtures thereof, a total of 0.5 to 5 wt .-% of at least one wax having a melting point of 65 to 150 ° C, selected from hydrogenated castor oil, and 0.5 to 8 wt .-% of at least one wax are contained with a melting point of 25 to ⁇ 50 ° C.
  • the sticks according to the invention contain a total of 0.5-8% by weight, preferably 1-6 Wt .-%, particularly preferably 3-4% by weight, of at least one wax having a melting point of 25 to ⁇ 50 ° C.
  • Preferred waxes having a melting point in the range of 25 - ⁇ 50 ° C are selected from coconut fatty acid glycerol mono-, di- and triesters, which may be partially cured or fully cured, mixtures of coconut fatty acid glycerol mono-, di- and triesters, blends partially hydrogenated or fully cured coconut fatty acid glycerol mono-, di- and tri-esters, partially hydrogenated or fully hydrogenated vegetable oils, butyrospermum parkii (shea butter), and esters of saturated C 8 -C 8 monohydric alcohols with saturated C 2 -C 8 monocarboxylic acids as well as mixtures of these substances.
  • Kokosfett Textreglyceride especially those with the INCI name Cocoglycerides, in particular the commercial products Novata ® (ex Cognis), particularly preferably a mixture of C 2 -C 8 mono-, di- and triglycerides, which is in the range 30-32 ° C melts, as it is marketed, eg under the trade name Novata ® AB from Cognis, as well as hardened and partially hardened Kokosfettchureglyceride, especially those with the INCI name Hydrogenated Cocoglycerides, especially obtainable as products of the Softisan- row (Sasol Germany GmbH) with the INCI Named Hydrogenated Cocoglycerides, especially Softisan 100, 133, 134, 138, 142.
  • esters of saturated, monohydric C 8 -C 8 alcohols with saturated C 2 -C 8 monocarboxylic acids are stearyl laurate, cetearyl stearate (e.g. . Crodamol ® CSS), cetyl palmitate (z. B. Cutina ® CP) and myristyl myristate (z. B. Cetiol ® MM).
  • Particularly preferred waxes having a melting point in the range 25-50 ° C are selected from mixtures of coconut fatty acid glycerol mono-, di- and triesters, blends of partially cured or fully cured coconut fatty acid glycerol mono-, di- and triesters, partially cured or fully cured vegetable oils, butyrospermum parkii (shea butter), stearyl laurate, cetearyl stearate, cetyl palmitate and myristyl myristate and mixtures thereof.
  • each based on their total weight a total of 15 to 25 wt .-% of at least one solid under normal conditions wax component, wherein a total of 12 to 22 wt .-% of at least one linear and saturated C 4 -C 22 alkanol, selected from Cetyl alcohol, stearyl alcohol, arachidyl alcohol and behenyl alcohol and mixtures thereof, a total of 0.5 to 5 wt .-% of at least one wax having a melting point of 65 to 150 ° C, selected from hydrogenated castor oil, and 0.5 to 8 wt .-% at least a wax having a melting point of from 25 to ⁇ 50 ° C, selected from mixtures of coconut fatty acid glycerol mono-, di- and triesters, mixtures of partially cured or fully hardened coconut fatty acids, mono-, di- and triesters, partially hydrogenated or fully hydrogenated vegetable oils, Butyrospermum Parkii (shea butter), stearyl
  • water-soluble surfactants are basically all in the system to 1 wt .-% at 20 ° C soluble and water at 20 ° C to at least 1 wt .-% soluble surfactants. Although the structure and ionogeneity are insignificant per se, nonionic surfactants, in particular the solid addition products of the ethylene oxide to fatty acid molecules having at least one alkoxylable group, appear to be preferred at normal temperature (20 ° C.).
  • Such suitable surfactants are, for example, the addition products of 10 to 40 mol of ethylene oxide to linear fatty alcohols having 16 to 22 carbon atoms, to fatty acids having 12 to 22 carbon atoms, to fatty acid alkanolamides, to fatty acid monoglycerides, to sorbitan fatty acid monoesters, to fat acid alkanolamides, fatty acid triglycerides, eg hardened castor oil, methyl glucoside monofatty acid esters and mixtures thereof.
  • Further inventively preferred compositions contain at least one oil-in-water emulsifier. Preferred oil-in-water emulsifiers have an HLB value of more than 7. Other preferred oil-in-water emulsifiers are nonionic.
  • HLB (100-L): 5 where L is the weight fraction of the lipophilic groups, that is the fatty alkyl or fatty acyl groups, in the ethylene oxide adducts, expressed in weight percent.
  • nonionic oil-in-water emulsifiers which are suitable according to the invention, it is particularly preferable to use a mixture of nonionic oil-in-water emulsifiers in order to be able to optimally adjust the properties of the compositions according to the invention, such as unfired or washable.
  • the individual emulsifier components thereby deliver a proportion to the total HLB value or average HLB value of the oil-in-water emulsifier mixture in accordance with their proportion of the total amount of oil-in-water emulsifiers.
  • compositions according to the invention may also contain only a single oil-in-water emulsifier, preferably with an HLB value in the range from 11 to 17, particularly preferably 12. 15 and most preferably 13-14.
  • Preferred cosmetic compositions of the invention are characterized in that which are non-ionic oil-in-water emulsifiers selected from ethoxylated C 8 - C 24 alkanols with an average of 10 - 100 moles of ethylene oxide per mole, ethoxylated C 8 -C 24 -carboxylic acids with an average of 10 - 100 moles of ethylene oxide per mole, with an average of 20 - 100 moles of ethylene oxide per mole of ethoxylated sorbitan monoesters of linear saturated and unsaturated C12 - C 30 carboxylic acids, which may be hydroxylated, especially those of myristic acid, palmitic acid, stearic acid or of mixtures of these fatty acids , Silicone copolyols with ethylene oxide units or with ethylene oxide and propylene oxide units, alkyl mono- and oligoglycosides having 8 to 22 carbon atoms in the alkyl radical and their ethoxylated analogs,
  • the ethoxylated C 8 -C 24 -alkanols have the formula R 0 (CH 2 CH 2 O) n ll, where R is a linear or branched alkyl and / or alkenyl radical having 8-24 carbon atoms and n, the average number of Ethylene oxide units per molecule, for numbers from 10 to 100, preferably 10 to 30, moles of ethylene oxide to 1 mole of caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmitoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, Elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol, and technical mixtures thereof.
  • adducts of 10-100 moles of ethylene oxide with technical fatty alcohols having 12-18 carbon atoms, such as coconut, palm, palm kernel or tallow fatty alcohol are suitable.
  • the ethoxylated C 8 -C 24 carboxylic acids have the formula R 0 (CH 2 CH 2 O) n H, where R 0 is a linear or branched saturated or unsaturated acyl radical having 8-24 carbon atoms and n, the average number of ethylene oxide Units per molecule, for numbers from 10 to 100, preferably 10 to 30, moles of ethylene oxide to 1 mole caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, cetylic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, arachidic , Gadoleic acid, behenic acid, erucic acid and brassidic acid and their technical mixtures.
  • Adducts of 10 to 100 moles of ethylene oxide with technical fatty acids containing 12 to 18 carbon atoms, such as coconut, palm, palm kernel or tallow fatty acid, are also suitable. Particularly preferred are PEG-40 monostearate, PEG-50 monostearate, PEG-100 monostearate, PEG-50 monooleate, PEG-100 monooleate, PEG-50 monolaurate and PEG-100 monolaurate.
  • C 2 -C 8 -alkanols or the C 2 -C 8 -carboxylic acids with in each case 10 to 30 units of ethylene oxide per molecule and also mixtures of these substances, in particular ceteth-10, ceteth-12, ceteth-20, ceteth- 30, steareth-10, steareth-12, steareth-20, steareth-30, ceteareth-10, ceteareth-12, ceteareth-20, ceteareth-30, laureth-12 and beheneth-20.
  • Preferred ones having on average 20-100 moles of ethylene oxide per mole of ethoxylated sorbitan monoesters of linear saturated and unsaturated C 2 -C 30 carboxylic acids which may be hydroxylated are selected from Polysorbate-20, Polysorbate-40, Polysorbate-60 and Polysorbate-80. Furthermore, preference is given to using C 8 -C 22 -alkyl mono- and -oligoglycosides.
  • C 8 -C 22 -alkyl mono- and - oligoglycosides are known, commercially available surfactants and emulsifiers. They are prepared in particular by reacting glucose or oligosaccharides with primary alcohols having 8-22 carbon atoms.
  • glycoside radical monoglycosides in which a cyclic sugar residue is glycosidically linked to the fatty alcohol and oligomeric glycosides having a degree of oligomerization of up to about 8, preferably 1-2, are suitable.
  • the degree of oligomerization is a statistical mean, which is based on a homolog distribution typical for such technical products. Products which are obtainable under the trademark Plantacare ®, a glucosidically bonded C 8 -C 6 alkyl group included in an oligoglucoside whose average degree of oligomerization with 1-2, particularly 1, 2 - 1, 4, is located.
  • Particularly preferred C 8 -C 22 alkyl mono- and oligoglycosides are selected from octyl glucoside, decyl glucoside, lauryl glucoside, palmityl glucoside, isostearyl glucoside, stearyl glucoside, arachidyl glucoside and behenyl glucoside and mixtures thereof.
  • the glucamine-derived acylglucamides are also suitable as nonionic oil-in-water emulsifiers.
  • Ethoxylated sterols, in particular ethoxylated soy sterols are also suitable oil-in-water emulsifiers according to the invention.
  • the degree of ethoxylation must be greater than 5, preferably at least 10, in order to have an HLB value greater than 7.
  • Suitable commercial products are, for. PEG-10 Soy Sterol, PEG-16 Soy Sterol and PEG-25 Soy Sterol.
  • Particularly preferred Diglycerinmonocaprylat, Diglycerinmonocaprat, diglycerol, Triglycerinmonocaprylat, tri- are glycerol monocaprate, triglycerol, Tetraglycerinmonocaprylat, Tetraglycerinmonocaprat, Tetraglycerinmonolaurat, Pentaglycerinmonocaprylat, Pentaglycerinmonocaprat, penta glycerol, Hexaglycerinmonocaprylat, Hexaglycerinmonocaprat, monolaurate Hexaglycerin-, Hexaglycerinmonomyristat, Hexaglycerinmonostearat, Decaglycerinmonocaprylat, Decaglycerinmonocaprat, decaglyceryl monolaurate, decaglyceryl monomyristate , deca- glycerinmonoisostearat, hydroxystearate decagly
  • organosiloxane-oxyalkylene copolymers are selected from organosiloxane-oxyalkylene copolymers.
  • Preferred organosiloxane-oxyalkylene copolymer O / W emulsifiers are selected from compounds of the general structural formulas (I), (II), (III), (IV) and (V),
  • the radicals R independently of one another represent a linear or branched C Cso-alkyl group or an optionally substituted phenyl group
  • the radicals R 2 are independently of one another the groups -C c H 2 C- O- (C 2 H 4 O-) a (C 3 H 6 0-) b R 5 or -C c H2c-O- (C 2 H 4 O-) a R 5
  • the radicals R 3 and R 4 independently of one another represent a linear or branched C 1 -C 4 -alkyl group and preferably methyl groups which R 5 independently represent a hydrogen atom or a linear or branched C 1 -C 4 alkyl group and preferably represent a hydrogen atom or a methyl group
  • m represents a number from 0-20
  • n represents a number from 0-500
  • p represents a number from 1-50
  • a represents a number from 0-50
  • b represents
  • organosiloxane-oxyalkylene copolymer is, for example, below the trade name Dow Corning 190 (INCI: PEG / PPG-18/18 Dimethicone).
  • organosiloxane-oxyalkylene copolymer is, for example available under the trade designation Dow Corning 193 (INCI: PEG-12 Dimethicone).
  • organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Silwet L-77.
  • organosiloxane-oxyalkylene copolymer is available, for example, in a mixture with cyclomethicone under the trade name Mirasil DMCO (INCI: cyclomethicone, PEG / PPG-22/24 dimethicone).
  • organosiloxane-oxyalkylene Copolymer is available, for example, under the trade name Dow Corning Q2-5220 (INCI: PEG / PPG-1 7/1 8 Dimethicone).
  • organosiloxane-oxyalkylene copolymer is for example, under the trade name Abil B 881 84 (INCI: PEG / PPG-20/6 Dimethicone) available.
  • organosiloxane-oxyalkylene copolymer is available, for example, under the trade name Abil B 8851 (INCI: PEG / PPG-1 4/4 Dimethicone).
  • compositions according to the invention are characterized in that at least one oil-in-water emulsifier, preferably at least one nonionic oil-in-water emulsifier, in a total amount of 0.5-1.0% by weight, preferably 1-9% by weight %, more preferably 1.5-8% by weight, most preferably 2-3% by weight, and also 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6, 5, 7, 7, 5, and 8 wt .-%, based on the total composition.
  • compositions according to the invention contain, in addition to the antiperspirant active substances, at least one deodorising aromatic alcohol of the structure (AA-1), R 5 R 3 R 1 ) - OH (AA-1)
  • R - R 6 independently a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and which may be substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, or an alkenyl group having 2 to 10 Carbon atoms which may be linear or branched and which may be substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms
  • R 7 - R independently a hydrogen atom, a halogen atom, in particular a chlorine atom, or an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and which may be substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, in particular having a methoxy group
  • m 0 or 1
  • n, o, p are independently integers from 0 to 10, wherein at least one of the values n, o, p is 0.
  • Deodorising aromatic alcohols of structure (AA-1) which are preferred according to the invention are selected from phenoxyethanol, phenoxyisopropanol (3-phenoxy-propan-2-ol), anisalcohol,
  • Further particularly preferred alcohols of the structure AA-1 are those in which at least one of the radicals R 1 , R 2 , R 3 , R 4 , R 5 or R 6 ⁇ H.
  • Examples of the C to C 5 -alkyl radicals mentioned as substituents in the compounds used according to the invention are the groups methyl, ethyl, propyl, isopropyl, n-butyl, tert-butyl, n-pentyl, amyl, isoamyl.
  • Ethyl, methyl, propyl, isopropyl, n-butyl, tert-butyl, n-pentyl, amyl, isoamyl are preferred alkyl radicals, particularly preferred are methyl and n-pentyl.
  • C r to C 4 -alkoxy radicals preferred according to the invention are, for example, a methoxy or an ethoxy group.
  • a C r to C 5 -hydroxyalkyl group a hydroxymethyl, a 2-hydroxyethyl, a 3-hydroxypropyl or a 4-hydroxybutyl group may be mentioned.
  • a 2-hydroxyethyl group is particularly preferred.
  • a particularly preferred C 2 to C 4 polyhydroxyalkyl group is the 1,2-dihydroxyethyl group.
  • halogen atoms are F, Cl or Br atoms
  • Cl atoms are very particularly preferred.
  • Particularly preferred deodorant aromatic alcohols of the structure (AA-1) according to the invention are selected from anisalcohol, 2-methyl-5-phenyl-pentane-1-ol, 1, 1-dimethyl-3-phenyl-propan-1-ol, 3 -Phenylpropan-1-ol, 4-phenylbutan-1-ol, 5-phenylpentan-1-ol, 2-benzylheptan-1-ol, 2,2-dimethyl-3-phenylpropan-1-ol and 2-n-pentyl 3-phenylpropane-1-ol. Extraordinary preference is given to 2-benzylheptan-1-ol.
  • compositions of the present invention include anhydrous ethanol and / or at least one anhydrous polyhydric alcohol having from 3 to 9 carbon atoms, which is liquid under normal conditions, and / or at least one polyethylene glycol (PEG), which is liquid under normal conditions.
  • PEG polyethylene glycol
  • These include 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1,2-pentanediol and 1,5.
  • Pentanediol such as 1, 2-hexanediol and 1, 6-hexanediol
  • hexanetriols such as 1, 2,6-hexanetriol
  • 2-ethyl-2-hydroxymethyl-1, 3-propanediol diethylene glycol, triethylene glycol, PEG-8, dipropylene glycol col, tripropylene glycol, diglycerol and triglycerol.
  • Particularly preferred are anhydrous ethanol and / or 1, 2-propylene glycol.
  • compositions according to the invention contain at least one perfume and / or at least one perfume oil.
  • fragrances or perfume oils individual fragrance compounds, e.g. the synthetic products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type are used.
  • Preferred compositions according to the invention comprise at least one perfume and / or at least one perfume oil in a total amount of 0.1-10% by weight, preferably 0.5-8% by weight, more preferably 1-6% by weight, most preferably 2 - 5 wt .-%, each based on the total weight of the composition.
  • Further preferred compositions according to the invention contain at least one encapsulated perfume and / or at least one encapsulated perfume oil.
  • compositions according to the invention are free of ethanol. In a further particularly preferred embodiment, the compositions according to the invention are free of isopropanol. In a further particularly preferred embodiment, the compositions according to the invention are free from ethanol and isopropanol.
  • compositions according to the invention contain, in addition to the at least one deodorant double salt of the alum type b) and in addition to the claimed component c), at least one further deodorant active substance.
  • deodorant active ingredients are selected from mineral deodorant active substances, odor absorbers, inorganic moisture absorbers, deodorizing ion exchangers, germ-inhibiting substances, prebiotic substances and also enzyme inhibitors and, particularly preferred, combinations of said deodorant active substances.
  • the mineral deodorant or moisture absorbents preferably include odor-absorbing and / or moisture-absorbing silicates such.
  • Unmodified silicates serve as odor absorbers or moisture absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention.
  • the silicates which are particularly advantageous according to the invention include, in particular, unmodified phyllosilicates and, among these, in particular montmorillonite, kaolinite, IIIit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum.
  • Such mineral deodorant or moisture absorbents are preferably in a total amount of 0.1 to 5 wt .-%, preferably 0.5 to 3 wt .-%, particularly preferably 0.7 to 2 wt .-%, each based on the entire composition, included.
  • Further advantageous odor absorbers are, for example, zinc ricinoleate, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll.
  • germ-inhibiting or antimicrobial active substances are understood to mean those wrinkles which reduce the number of skin germs participating in the formation of the odor or inhibit their growth.
  • These organisms include, among others, various species from the group of staphylococci, the group of corynebacteria, anaerococci and micrococci.
  • Preferred germinal or antimicrobial active substances according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a series of plant extracts and zinc compounds.
  • triclosan chlorhexidine and chlorhexidine gluconate
  • 3,4,4'-trichlorocarbanilide bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphen bromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalconium saccharinates, Benzethonium chloride, cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide, methylbenzedonium chloride.
  • phenol disodium dihydroxyethylsulfosuccinyl undecylenate, sodium bicarbonate, zinc lactate, sodium phenolsulfonate and zinc phenolsulfonate, ketoglutaric acid, terpene alcohols such as.
  • chlorophyllin copper complexes ⁇ -monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, particularly preferably a- (2-ethylhexyl) glycerol, commercially available as Sensiva ® SC 50 (ex Schülke & Mayr), carboxylic acid esters of mono-, di- and triglycerol (eg glycerol monolaurate, diglycerol monocaprinate), lantibiotics and plant extracts (eg green tea and components of lime blossom oil).
  • Sensiva ® SC 50 ex Schülke & Mayr
  • carboxylic acid esters of mono-, di- and triglycerol eg glycerol monolaurate, diglycerol monocaprinate
  • lantibiotics and plant extracts eg green tea and components of lime blossom oil.
  • deodorant active substances are selected from so-called prebiotically active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor-causing germs of the skin microflora, but not the desired ones, that is, the non-odor-forming germs forming a healthy skin micro flora.
  • active ingredients which are disclosed in the published patent applications DE 10333245 and DE 10 2004 01 1 968 as prebiotically effective, also included; these include conifer extracts, in particular from the group of Pinaceae, and plant extracts from the group of Sapindaceae, Araliaceae, Lamiaceae and Saxifragaceae, in particular extracts from Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures of these substances.
  • Enzyme inhibitors include substances which are responsible for the decomposition of sweat.
  • chen enzymes in particular the arylsulfatase, ß-glucuronidase, aminoacylase, cystathionine beta-lyase esterases, lipases and / or lipoxigenase inhibit, for.
  • B. trialkylcitric acid in particular triethyl citrate, or zinc glycinate.
  • Further preferred deodorant impurities are selected from silver salts, in particular silver citrate, dihydrogen silver citrate, silver lactate and silver sulfate, soluble complex salts of silver, colloidal silver and silver zeolites.
  • compositions according to the invention contain at least one additional deodorant active ingredient selected from silver salts, soluble complex salts of silver, colloidal silver and silver zeolites, arylsulfatase inhibitors, ⁇ -glucuronidase inhibitors, aminoacylase inhibitors, cystathionine-beta-lyase inhibitors, esterase Inhibitors, lipase inhibitors and lipoxigenase inhibitors, ⁇ -monoalkyl glycerol ethers having a branched or linear saturated or unsaturated, optionally hydroxylated C 6 -C 22 -alkyl radical, in particular a- (2-ethylhexyl) glycerol ether, prebiotic components, trialkyl citric acid esters, in particular Triethyl citrate, active ingredients which reduce or inhibit the growth of the number of skin germs involved in the formation of odor from the group of staphylococci, corynebacteria, anaerococci, microco
  • compositions according to the invention contain at least one additional deodorant active substance in a total amount of 0.1-10% by weight, preferably 0.2-7% by weight, more preferably 0.3-5% by weight and most preferably 0.4 - 1, 0 wt .-%, further preferably 0.5, 0.6, 0.7, 0.8 and 0.9 wt .-%, based on the total weight of the active substance in the total composition.
  • a further preferred embodiment of the invention is characterized in that 0.01 to 5 wt .-%, preferably 0.05 to 2 wt .-%, particularly preferably 0.1 to 1 wt .-%, each based on the total composition , a mineral mixture obtained from a natural mineral water, a thermal water or a natural healing water is included.
  • Natural mineral water is based on the definition of the German Mineral and Table Water Ordinance (MinTafWV, ⁇ 2) .
  • the mineral mixture is considered to be the solid residue of the named waters.
  • Occupationally preferred mineral mixtures originate from the thermal water of La Toja (Spain), Bad Blumau, Bad Radkersburg, Aachen, Wiesbaden (all Germany), Carlsbad (Czech Republic), La Bourboule, Enghien-les-bains, Allevard-les-bains, Digne, Nyrac-les-bains, Lons le Saunier, Eaux Bonnes, Rochefort, les Fumades, Saint Christau, Uriage-les-bains, la Roche-Posay (all France) or the natural mineral or medicinal waters of Evian, Volvic, Vichy, Avene, Vittel (all France), Gerolstein or laboringen (Germany).
  • Cocoglycerides (FP 30-32 ° C,
  • Cocoglycerides (FP 30-32 ° C,
  • Cocoglycerides (Novata AB)
  • Cocoglycerides (Novata AB, FP 30-32 ° C) 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des compositions antisudorales anhydres ayant une performance antisudorale améliorée, lesdites compositions étant confectionnées comme une matière indéformable à 40°C et apte à être étalée sur la peau, et contenant au moins un principe actif antisudoral, au moins un sel double de type alun ayant la formule générale MIMIII(SO4)2 ⋅ x H2O (où MI = un cation monovalent, sélectionné parmi des ions de potassium, de sodium, de rubidium, de césium et d'ammonium; MIII = un cation trivalent sélectionné parmi des ions d'aluminium, de gallium, d'indium, de scandium, de titane et de vanadium; x = nombre rationnel compris entre 0 et 12, y compris 0) et 0,0005 à 5 % en poids d'au moins un composé contenant de l'oxyde de silicium, sélectionné parmi les acides siliciques modifiés hydrophobes et les silicates et les silicates en feuillets modifiés hydrophobes, ainsi qu'un excipient liquide anhydre dans des conditions normales.
PCT/EP2011/062609 2010-07-23 2011-07-22 Bâtonnets antitranspiration contenant des sels doubles Ceased WO2012010683A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010038357.0 2010-07-23
DE102010038357A DE102010038357A1 (de) 2010-07-23 2010-07-23 Doppelsalz-haltige Antitranspirant-Stifte

Publications (2)

Publication Number Publication Date
WO2012010683A2 true WO2012010683A2 (fr) 2012-01-26
WO2012010683A3 WO2012010683A3 (fr) 2013-12-12

Family

ID=44629008

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/062609 Ceased WO2012010683A2 (fr) 2010-07-23 2011-07-22 Bâtonnets antitranspiration contenant des sels doubles

Country Status (2)

Country Link
DE (1) DE102010038357A1 (fr)
WO (1) WO2012010683A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526311A (zh) * 2012-02-21 2012-07-04 简福川 一种治疗脚汗症的中药制剂

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3079648A1 (fr) * 2013-12-11 2016-10-19 Colgate-Palmolive Company Composition anti-transpirante/déodorante
IT201900011775A1 (it) * 2019-07-17 2021-01-17 Vito Greco Composizione dermocosmetica antisudorazione

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
GB1347950A (en) 1971-03-08 1974-02-27 Bristol Myers Co Antiperspirant aerosol system
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
BE825146A (fr) 1974-02-04 1975-08-04 Complexes d'antitranspiration
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US20040009133A1 (en) 2002-07-12 2004-01-15 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
DE10333245A1 (de) 2003-07-21 2005-07-28 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
DE102004011968A1 (de) 2004-03-10 2005-09-29 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2299506B (en) 1995-04-03 1999-04-14 Unilever Plc Antiperspirant actives and compositions
JP5302523B2 (ja) * 2007-08-20 2013-10-02 株式会社 資生堂 皮膚外用剤

Patent Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
GB1347950A (en) 1971-03-08 1974-02-27 Bristol Myers Co Antiperspirant aerosol system
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
BE825146A (fr) 1974-02-04 1975-08-04 Complexes d'antitranspiration
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6074632A (en) 1997-06-25 2000-06-13 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6245325B1 (en) 1998-08-19 2001-06-12 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6649152B2 (en) 2000-10-25 2003-11-18 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 Al content
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US20040009133A1 (en) 2002-07-12 2004-01-15 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
DE10333245A1 (de) 2003-07-21 2005-07-28 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
DE102004011968A1 (de) 2004-03-10 2005-09-29 Henkel Kgaa Präbiotisch wirksame Pflanzenextrakte

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KIRK-OTHMER: "Encyclopedia of Chemical Technology", vol. 8, 1979, pages: 913 - 916

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526311A (zh) * 2012-02-21 2012-07-04 简福川 一种治疗脚汗症的中药制剂

Also Published As

Publication number Publication date
DE102010038357A1 (de) 2012-01-26
WO2012010683A3 (fr) 2013-12-12

Similar Documents

Publication Publication Date Title
EP2349184B1 (fr) Compositions de déodorant anhydres à efficacité renforcée, appliquées sans aérosol
EP2099529A2 (fr) Stick antitranspirant sans traces
EP2349185B1 (fr) Compositions de déodorant anhydres à efficacité renforcée, appliquées sous forme d'aérosol
WO2011003673A2 (fr) Compositions cosmétiques contenant des suspensions de sels d'argent
US20130280175A1 (en) Water-containing antiperspirant compositions with improved white mark protection
EP2480193B1 (fr) Anti-transpirants non aérosol sans eau à libération améliorée d'agents
WO2012010684A2 (fr) Applicateurs à bille antitranspiration contenant des sels doubles
DE102006040302A1 (de) Antitranspirant- und Deodorant-Zusammensetzungen mit verbesserter Pflegewirkung
EP2665463B1 (fr) Stick antitranspirant ayant une meilleure stabilité à long terme
DE102011083872A1 (de) Wasserfreie Kosmetika mit einem natürlichen Feuchtigkeitsabsorber
WO2009101000A2 (fr) Déodorants et/ou antitranspirants à fragrance et à capacité d'absorption d'odeurs à effet renforcé
EP2515835A2 (fr) Sprays antitranspirants sans eau à efficacité améliorée
WO2012010683A2 (fr) Bâtonnets antitranspiration contenant des sels doubles
EP2370050A2 (fr) Nouveaux déodorants et anti-transpirants permettant d'inhiber la croissance pileuse
WO2010145921A2 (fr) Compositions cosmétiques contenant des sels d'argent sélectionnés
EP2442780B1 (fr) Compositions cosmétiques contenant du lactate d'argent
EP2059225A1 (fr) Compositions antitranspirantes et désodorisantes de potentiel irritatif réduit
WO2014187576A1 (fr) Association de principes actifs désodorisante
DE102012218233A1 (de) Kosmetische Seifengelstifte mit antibakterieller Wirkung
EP3057568A1 (fr) Agent cosmétique anti-transpiration contenant des acides alkylsulfoniques
WO2010145922A2 (fr) Compositions anti-transpirantes contenant du citrate d'argent
EP2442781B1 (fr) Compositions cosmétiques contenant du sulfate d'argent
WO2016062487A1 (fr) Antitranspirants à efficacité accrue

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 11736087

Country of ref document: EP

Kind code of ref document: A2